Clinical Trials Directory

Trials / Completed

CompletedNCT00730132

Observational Study of Approaches to Lipid-Lowering Therapy in Russian Patients With Coronary Heart Disease <<Treat to Goal>> (Study P05464)

Observational Study of Approaches to Lipid-lowering Therapy in Russian Patients With Coronary Heart Disease (<<Treat to Goal>>)

Status
Completed
Phase
Study type
Observational
Enrollment
712 (actual)
Sponsor
Organon and Co · Industry
Sex
All
Age
18 Years – 75 Years
Healthy volunteers
Not accepted

Summary

This study is being performed to evaluate what variants of lipid-lowering therapy are used in Russian clinical practice in coronary heart disease (CHD) patients with hypercholesterolemia in whom the initial statin therapy did not achieve low density lipoprotein-cholesterol (LDL-C) goals. Additionally, the efficacy and safety of all variants of modified lipid-lowering therapy are to be evaluated.

Detailed description

Given the observational nature of this study and that the assessment of a specific hypothesis is not foreseen, statistical assumption is not planned and the sample size calculation was not performed. Taking into consideration the available data on the established safety profile of the therapy with statins and combination of ezetimibe with statins it has been suggested that a sample size of 750 patients will be sufficient to identify adverse events profile. The treatment effects will be characterized by descriptive and frequency parameters.

Conditions

Interventions

TypeNameDescription
DRUGEzetimibeDosage determined by the investigator based on standard and applicable routine clinical practice for CHD and hypercholesterolemia patients
DRUGStatinStatin titration for the Statin Dose Titration group, and new statin treatment and dosage for the New Statin group, determined by the investigator based on standard and applicable routine clinical practice for CHD and hypercholesterolemia patients

Timeline

Start date
2008-01-01
Primary completion
2009-08-01
Completion
2009-08-01
First posted
2008-08-08
Last updated
2022-02-09
Results posted
2010-10-11

Source: ClinicalTrials.gov record NCT00730132. Inclusion in this directory is not an endorsement.